Goldberg Mark Alan
- SEC CIK
- 0001532475
No open-market purchases or sales filed in the past year.
Current role at each company
- BPMC Blueprint Medicines CorpDirectoras of Jul 21, 2025
- CBIO Crescent Biopharma, Inc.Directoras of May 1, 2024
- IMGN ImmunoGen, Inc.Directoras of Feb 12, 2024
- ACGN Aceragen, Inc.Directoras of Jun 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Goldberg Mark Alan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BPMC Blueprint Medicines Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Goldberg Mark AlanDirector | PPurchase | +5.00K | $59.98 | +$299.9K | +86.0%10.8K after |